Publicacions destacades

Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort

Trottier, B; Yang, CJ; Watanabe, D; Marchetti, G; Elbirt, D;

(...)

Heinzkill, M; Marongiu, A; Ramroth, J; D'Amato, L; Mallolas, J.

Referència:
Hiv Research And Clinical Practice 2025.
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?

Sempere, A; Alonso, R; Berrocal, L; Calvo, J; Foncillas, A;

(...)

Martinez, E; Miró, JM; de Lazzari, E; Mallolas, J; Ambrosioni, J.

Referència:
Infectious Diseases And Therapy 2025.
Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain

Chivite, I; Guilera, V; Callau, P; Aguiló, R; de Lazzari, E;

Merino, MJ; Diaz, L; Carrodeguas, A; González-Sánchez, JL; Mallolas, J.

Referència:
Plos One 2025.
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability

De la Mora, L; Laguno, M; Torres, B; Chivite, I; Foncillas, A;

(...)

Miquel, L; Blanch, J; Short, D; Mallolas, J; Martínez-Rebollar, M.

Referència:
Infectious Diseases And Therapy 2025.
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study

Ugarte, Ainoa; De La Mora, Lorena; De Lazzari, Elisa; Chivite, Ivan; Fernandez, Emma;

(...)

Calvo, Julia; Blanco, Jose Luis; Martinez, Esteban; Mallolas, Josep; Torres, Berta.

Referència:
Journal Of Antimicrobial Chemotherapy 2024.
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

Inciarte, Alexy; de la Mora, Lorena; Huaier-Arriazu, Emilio; Torres, Berta; Canizares, Silvia;

(...)

Martinez, Esteban; Blanco, Jose Luis; Miro, J M; Martinez-Rebollar, Maria; Mallolas, Josep.

Referència:
Infectious Diseases And Therapy 2024.
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Ambrosioni, J; Diaz, NA; Marzolini, C; Dragovic, G; Imaz, A;

(...)

Khoo, S; Burger, D; Cortes, CP; Naous, N; Molto, J.

Referència:
Infectious Diseases And Therapy 2024.
Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020

Toyos, S; Berrocal, L; González-Cordó, A; Inciarte, A; de la Mora, L;

(...)

Blanco, JL; Martínez, E; Miró, JM; Mallolas, J; Torres, B.

Referència:
Eurosurveillance 2023.
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement

Laguno, M; Ugarte, A; Martinez-Rebollar, M; Sobrino, Y; Font, G;

(...)

Rojas, J; Cordón, E; Blanco, JL; Martínez, E; Mallolas, J.

Referència:
Enfermedades Infecciosas Y Microbiologia Clinica 2023.
Immunological and virological findings in a patient with exceptional post-treatment control: a case report

Climent, N; Ambrosioni, J; González, T; Xufré, C; Casadellà, M;

(...)

Grau-Expósito, J; Mallolas, J; Alcamí, J; Sánchez-Palomino, S; Miró, JM.

Referència:
Lancet Hiv 2023.